Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ranitidine Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20040231

Company浙江莎普爱思药业股份有限公司

Registration Date

September 20, 2024

Drug Information

Generic Name

盐酸雷尼替丁氯化钠注射液

Trade Name

菁璐

Dosage Form

注射剂

Strength

100ml：盐酸雷尼替丁0.1g（以雷尼替丁计）与氯化钠0.9g

Drug Type

化学药品

Registration Date

September 20, 2024

Company Information

Applicant Company

Company Name浙江莎普爱思药业股份有限公司

Company Address

浙江省平湖市经济开发区新明路1588号

Manufacturing Company

Company Name浙江莎普爱思药业股份有限公司

Company Address

浙江省平湖市经济开发区新明路1588号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸雷尼替丁氯化钠注射液 - NMPA 批准文号 | MedPath